Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Central corneal thickness differences do not explain IOP lowering
Fort Lauderdale, FL-Central corneal thickness (CCT) influences IOP measurement and almost certainly plays an important role in pharmacokinetics. However, a recent study found that CCT did not significantly affect mean IOP despite differences in CCT between black and non-black patients who had been treated for open-angle glaucoma (OAG) or ocular hypertension (OHT).
Related Videos
Related Content
